// Company Overview //
| Stock Name | 弘和仁愛醫療集團有限公司 |
| Stock Code | 03869 |
| Company Full Name | 弘和仁愛醫療集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國從事醫院運營及管理,以及藥品批發業務。 |
| Listing Date | 2017-03-16 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | No data |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市海淀區知春路6號錦秋國際大廈B座1602室 |
| Business Address (Hong Kong) | No data |
| Place of Incorporation | No data |
| Listing Method | No data |
| Listing Board | Main Board |
| Website | http://www.hcclhealthcare.com |
| Share Registrar | 香港中央證券登記有限公司 |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
// Offering Information //
| Prospectus Date | 2017-02-28 |
| Offer Price | HK$ 12.80 / shares |
| Total Funds Raised | HK$ 42,670,080 |
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
// First Day Performance
| First Day Close | Loading... |
| First Day Open | HK$ 13.0 |
| First Day Change | 1.25% |
| First Day Volume | 7777800.0 |
| First Day Turnover | 99297800.0 |
// Price Chart //
// Use of Proceeds
| Use of Proceeds | 1、171.8百萬港元(50%)將用于戰略性收購位于中國的醫院;
2、61.8百萬港元(18%)將不時用于對我們所擁有或管理的醫院(非營利性醫院除外)進一步投資;
3、51.5百萬港元(15%)將用于醫院及我們不時擁有或管理的其他醫院的雇員培訓計劃、人才引進及學術研究活動;
4、24.1百萬港元(7%)將用于升級及改良我們的信息技術系統;
5、34.5百萬港元(10%)將用于為我們的營運資金、租金和物業相關開支及其他一般企業用途提供資金。 |
// Underwriting Syndicate //
联席账簿管理人 (1)
中国国际金融香港证券有限公司
联席牵头经办人 (1)
中国国际金融香港证券有限公司
// Cornerstone Investors //
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
| 1 |
安徽省中安健康养老服务 |
116,464,640 HKD |
— |
6.80% |
— |
6 months |
2017-09-16 |
// Directors & Management //
| Chairman | 陳帥 |
| Company Secretary | 何詠欣 |
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | Hony Capital Fund V, L.P.(70.19%);安徽省中安健康養老服務產業投資合夥企業(6.58%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.